Table 1.
Ref. | n | Line/treatment | Relevant data |
Nagahama et al[21] | 147 | First line doxorubicin | Severe cirrhosis, PS 2-3, tumour occupying > 50% liver do not respond to chemo |
Olweny et al[22] | 14 | First line doxorubicin | RR 79% |
Sciarrino et al[23] | First line doxorubicin | RR 10%-20% | |
Chlebowski et al[24] |
RR: Response rate.